Compare BioNTech SE - ADR (BNTX) vs Gartner Inc (IT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Gartner Inc — how do they compare? BioNTech SE - ADR trades at $89.89 (market cap $22.78B), while Gartner Inc trades at $132.89 (market cap $9.46B). The key difference: BioNTech SE - ADR is far larger — about 2.4× Gartner Inc's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Gartner Inc nearer its low. Which is the better fit depends on your goals.
| BNTX | IT | |
|---|---|---|
Market Cap | $22.78B | $9.46B |
Sector | Health | Technology |
52-Week High | $119.34 | $363.58 |
52-Week Low | $83.89 | $125.68 |
Enterprise Value | $6.45B | $11.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Gartner Inc
Based in Stamford, Conn., Gartner provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services and hosted nearly 80 IT conferences across the globe in 2007.
Read more on IT →
